Adicet Bio
ACET
#9709
Rank
โ‚น6.75 B
Marketcap
โ‚น722.51
Share price
-2.34%
Change (1 day)
1,091.99%
Change (1 year)

Revenue for Adicet Bio (ACET)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adicet Bio from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 โ‚น2.06 B185.54%
2021 โ‚น0.72 B-44.69%
2020 โ‚น1.30 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.450 TN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.099 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.335 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.671 TN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
โ‚น102.41 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
โ‚น185.56 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA